Skip to content

Chlorproethazine

NERVOUS SYSTEM

Also known as: 2-Chloro-10-(3-diethylaminopropyl)phenothiazine, RP 4909

ATC N05AA07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Chlorproethazine is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including DRD3, DRD2 and DRD4.

  • Molecular targets: DRD3, DRD2 and DRD4 (3 listed in DrugCentral).
  • ATC code: N05AA07 (Phenothiazines with aliphatic side-chain).
  • Molecular formula: C19H23ClN2S; molecular weight 346.92 g/mol.

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
D(3) dopamine receptorDRD3unknownKi 7.99
D(2) dopamine receptorDRD2unknownKi 7.98
D(4) dopamine receptorDRD4unknownKi 7.64

ATC classification

ATC codeTherapeutic hierarchy
N05AA07NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Phenothiazines with aliphatic side-chain

Chemical structure

Molecular formulaC19H23ClN2S
Molecular weight346.92 g/mol
CAS number84-01-5
InChIKeyDBOUGBAQLIXZLV-UHFFFAOYSA-N
PubChem CID65750
CCN(CC)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Chlorproethazine work?

Its molecular targets in DrugCentral include DRD3, DRD2 and DRD4.

What is the chemical formula of Chlorproethazine?

Chlorproethazine has the molecular formula C19H23ClN2S and a molecular weight of 346.92 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets3
Indications0
FormulaC19H23ClN2S
DrugCentral ID619
Interactive profile